文献速递慢性肾脏病

一项前瞻性横断面研究:在成人实体瘤患者中基于肌酐和胱抑素C估算肾小球滤过率

A prospective cross-sectional study estimated glomerular filtration rate from creatinine and cystatin C in adults with solid tumors.
PubMed 文献 · Kidney Int · 2022-01-12

该前瞻性横断面研究纳入1200例成人实体瘤患者,以51Cr-EDTA血浆清除率测定的mGFR为参考,比较CKD-EPI系列方程与Cockcroft-Gault(CG)方程的表现。结果显示CG方程准确性最差,eGFRcr-cys表现最佳,作者认为在肿瘤实践中不应优先使用CG方程,eGFRcr-cys可作为确认性检测。

要点

  • 在成人实体瘤患者中,CG方程准确性最差,1-P30为24.9%。
  • CKD-EPI肌酐方程1-P30为19.1%,优于CG方程。
  • eGFRcr-cys表现最佳,偏倚-2.0 ml/min/1.73m2,1-P30为7.8%。

核心结论

  • 在成人实体瘤患者中,CG方程不应优先于CKD-EPI方程使用,eGFRcr-cys可作为确认性检测。
  • 作者认为一项重要政策含义是在肿瘤实践和临床试验中采用普通实践指南推荐的GFR评估方法。

研究设计与样本

  • 前瞻性横断面研究,于2015年4月至2017年9月前瞻性招募1200例成人实体瘤患者。
  • 以51Cr-EDTA血浆清除率测定的mGFR为参考标准,比较CKD-EPI方程及其他方程与CG方程的表现。
  • 偏倚定义为mGFR与eGFR差值的中间值,准确性定义为估计值与mGFR相差超过30%的百分比(1-P30)。
  • 患者平均年龄58.8岁,平均mGFR为78.4 ml/min/1.73m2。

主要发现

  • eGFRcr方程的偏倚范围为-8.1至+6.1 ml/min/1.73m2。
  • CG方程准确性最差,1-P30(95%CI)为24.9(22.4-27.3)%。
  • CKD-EPI方程1-P30为19.1(16.8-21.2)%。
  • eGFRcr-cys表现最佳:偏倚-2.0(-2.6至-1.1)ml/min/1.73m2,1-P30为7.8(6.3-9.4)%。

临床怎么用

  • 作者认为在肿瘤实践和临床试验中不应优先使用CG方程,而应采用CKD-EPI方程。
  • 作者认为eGFRcr-cys可作为成人实体瘤患者的确认性检测。
  • 作者提出一项重要政策含义是在肿瘤实践和临床试验中采用普通实践指南推荐的GFR评估方法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Current guidelines recommend estimating glomerular filtration rate (eGFR) using creatinine (eGFRcr) with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation as the first test for GFR evaluation, but the Cockcroft-Gault (CG) equation is still commonly used in oncology practice and clinical trials despite increasing evidence of its inaccuracy compared to measured GFR (mGFR). Guidelines recommend eGFR using cystatin C (eGFRcys) or both markers (eGFRcr-cys) as a confirmatory test, but neither was carefully evaluated in cancer patients. Therefore, we compared performance of the CKD-EPI equations and others to the CG equation in adults with a variety of solid tumors. The mGFR was determined by plasma clearance of 51Cr-EDTA. Bias was defined as the median of the differences between mGFR and eGFR while accuracy was defined as the percentage of estimates that differed by more than 30% from the measured GFR (1-P30). We prospectively recruited 1,200 patients between April 2015 and September 2017 with a mean age and mGFR of 58.8 years and 78.4 ml/min/1.73m2, respectively. Bias among eGFRcr equations varied from -8.1 to +6.1 ml/min/1.73 m2. CG was the least accurate, 1-P30 (95% confidence interval) was 24.9 (22.4- 27.3)%; CKD-EPI had 1-P30 of 19.1 (16.8-21.2)% while eGFRcr-cys had the best performance: bias -2.0 (-2.6 to -1.1) ml/min/1.73m2 and 1-P30 7.8 (6.3-9.4)%. Thus, the CG equation should not be preferred over CKD-EPI equation, and eGFRcr-cys can be used as a confirmatory test in adults with solid tumors. Hence, a major policy implication would be to adopt general practice guideline-recommended methods for GFR evaluation in oncology practice and clinical trials.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Costa E Silva VT, Gil LA, Inker LA, et al. A prospective cross-sectional study estimated glomerular filtration rate from creatinine and cystatin C in adults with solid tumors. Kidney Int. 2022. PMID: 35032521. doi:10.1016/j.kint.2021.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。